Elsbernd Brian
Chief Legal Officer
Elsbernd Brian has filed 7 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jul 17, 2026.
On the most recent filing, Elsbernd Brian is listed as Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC. Inside the rolling window, Elsbernd Brian reported no open-market purchases and 1 open-market sale totaling $908K in CPRX.
Companies traded
Other insiders at CPRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$908K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Elsbernd Brian made?
Elsbernd Brian has filed 7 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.
Which companies does Elsbernd Brian trade?
Elsbernd Brian has filed SEC Form 4 disclosures for 1 company, including CPRX.
When was Elsbernd Brian's most recent SEC Form 4 filing?
Elsbernd Brian's most recent SEC Form 4 filing on Tracefour is dated Jul 17, 2026.
What is Elsbernd Brian's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Elsbernd Brian is listed as Chief Legal Officer.
What is Elsbernd Brian's total buy and sell value in the current window?
Inside the rolling retention window, Elsbernd Brian bought $0 and sold $908K based on SEC Form 4 filings.
What was Elsbernd Brian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 40,000 CPRX shares on 2025-11-12, worth $908K, per SEC Form 4 filings.